82 related articles for article (PubMed ID: 2674969)
1. Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein.
Belpaire FM; Bogaert MG
Prog Clin Biol Res; 1989; 300():337-50. PubMed ID: 2674969
[No Abstract] [Full Text] [Related]
2. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
Meijer DK; van der Sluijs P
Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
[No Abstract] [Full Text] [Related]
3. Blood binding and tissue transfer of drugs: the influence of alpha 1 acid glycoprotein binding.
Belaiba R; Riant P; Urien S; Brée F; Albengres E; Barré J; Tillement JP
Prog Clin Biol Res; 1989; 300():287-305. PubMed ID: 2674966
[No Abstract] [Full Text] [Related]
4. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
Huang Z; Ung T
Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
[TBL] [Abstract][Full Text] [Related]
5. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
Bree F; Houin G; Barre J; Riant P; Tillement JP
Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
[No Abstract] [Full Text] [Related]
6. [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].
Bender KI; Lutsevich AN
Farmakol Toksikol; 1987; 50(5):110-9. PubMed ID: 3319686
[No Abstract] [Full Text] [Related]
7. Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
Baumann P; Eap CB
Prog Clin Biol Res; 1989; 300():379-97. PubMed ID: 2674972
[No Abstract] [Full Text] [Related]
8. Drug binding to human alpha-1-acid glycoprotein in health and disease.
Kremer JM; Wilting J; Janssen LH
Pharmacol Rev; 1988 Mar; 40(1):1-47. PubMed ID: 3064105
[No Abstract] [Full Text] [Related]
9. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
Belpaire FM; Chindavijak B; Bogaert MG
J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
[TBL] [Abstract][Full Text] [Related]
10. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
Tillement JP; Duché JC; Barré J
Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
[TBL] [Abstract][Full Text] [Related]
11. Drug binding sites on human alpha-1-acid glycoprotein.
Müller WE
Prog Clin Biol Res; 1989; 300():363-78. PubMed ID: 2674971
[No Abstract] [Full Text] [Related]
12. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology.
Bruguerolle B; Arnaud C; Levi F; Focan C; Touitou Y; Bouvenot G
Prog Clin Biol Res; 1989; 300():199-214. PubMed ID: 2674964
[No Abstract] [Full Text] [Related]
13. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
Alván G
Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
[No Abstract] [Full Text] [Related]
14. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic crisis in the elderly.
ElDesoky ES
Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
[TBL] [Abstract][Full Text] [Related]
16. Impact of age-related alteration of plasma alpha 1-acid glycoprotein concentration on erythromycin pharmacokinetics in pigs.
Kinoshita T; Son DS; Shimoda M; Kokue E
Am J Vet Res; 1995 Mar; 56(3):362-5. PubMed ID: 7771705
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the interaction between alpha-1-acid glycoprotein and tamoxifen and its metabolites.
Paterson SC; Lim CK; Smith KD
Biomed Chromatogr; 2003; 17(2-3):143-8. PubMed ID: 12717803
[TBL] [Abstract][Full Text] [Related]
18. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
Oie S; Fiori F
J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.
Smith SA; Waters NJ
Pharm Res; 2018 Dec; 36(2):30. PubMed ID: 30593605
[TBL] [Abstract][Full Text] [Related]
20. An integrated pharmacokinetic and pharmacodynamic approach to controlled drug delivery.
Breimer DD
J Drug Target; 1996; 3(6):411-5. PubMed ID: 8863134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
